Hemotransmissive Infections Testing Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: HBEF841B4701EN
Market Monitor Global

Abstracts

Hemotransmissive Infections are the infections which are transferred through blood when infected person comes in contact. Severe diseases such as hepatitis C, hepatitis B and human immunodeficiency virus (HIV) are most common diseases spread via blood. Timely diagnosis of these diseases becomes important for their cure or management.

This report contains market size and forecasts of Hemotransmissive Infections Testing in Global, including the following market information:

Global Hemotransmissive Infections Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hemotransmissive Infections Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatitis B virus (HBV) DNA Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemotransmissive Infections Testing include Vector-Best, Atlas Medical, Launch Diagnostics, Creative Diagnostics, Shanghai Chemtron Biotech, Oscar Medicare, ABON Biopharm, Bio-Rad Laboratories and Trinity Biotech Manufacturing and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemotransmissive Infections Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemotransmissive Infections Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hemotransmissive Infections Testing Market Segment Percentages, by Type, 2021 (%)

• Hepatitis B virus (HBV) DNA Testing
• Hepatitis C virus (HCV) RNA Testing
• Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing

Global Hemotransmissive Infections Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hemotransmissive Infections Testing Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Hemotransmissive Infections Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hemotransmissive Infections Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemotransmissive Infections Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hemotransmissive Infections Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Vector-Best
• Atlas Medical
• Launch Diagnostics
• Creative Diagnostics
• Shanghai Chemtron Biotech
• Oscar Medicare
• ABON Biopharm
• Bio-Rad Laboratories
• Trinity Biotech Manufacturing
• Adaltis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemotransmissive Infections Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemotransmissive Infections Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMOTRANSMISSIVE INFECTIONS TESTING OVERALL MARKET SIZE

2.1 Global Hemotransmissive Infections Testing Market Size: 2021 VS 2028
2.2 Global Hemotransmissive Infections Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemotransmissive Infections Testing Players in Global Market
3.2 Top Global Hemotransmissive Infections Testing Companies Ranked by Revenue
3.3 Global Hemotransmissive Infections Testing Revenue by Companies
3.4 Top 3 and Top 5 Hemotransmissive Infections Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemotransmissive Infections Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemotransmissive Infections Testing Players in Global Market
  3.6.1 List of Global Tier 1 Hemotransmissive Infections Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemotransmissive Infections Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hemotransmissive Infections Testing Market Size Markets, 2021 & 2028
  4.1.2 Hepatitis B virus (HBV) DNA Testing
  4.1.3 Hepatitis C virus (HCV) RNA Testing
  4.1.4 Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
4.2 By Type - Global Hemotransmissive Infections Testing Revenue & Forecasts
  4.2.1 By Type - Global Hemotransmissive Infections Testing Revenue, 2017-2022
  4.2.2 By Type - Global Hemotransmissive Infections Testing Revenue, 2023-2028
  4.2.3 By Type - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemotransmissive Infections Testing Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Hemotransmissive Infections Testing Revenue & Forecasts
  5.2.1 By Application - Global Hemotransmissive Infections Testing Revenue, 2017-2022
  5.2.2 By Application - Global Hemotransmissive Infections Testing Revenue, 2023-2028
  5.2.3 By Application - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hemotransmissive Infections Testing Market Size, 2021 & 2028
6.2 By Region - Global Hemotransmissive Infections Testing Revenue & Forecasts
  6.2.1 By Region - Global Hemotransmissive Infections Testing Revenue, 2017-2022
  6.2.2 By Region - Global Hemotransmissive Infections Testing Revenue, 2023-2028
  6.2.3 By Region - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hemotransmissive Infections Testing Revenue, 2017-2028
  6.3.2 US Hemotransmissive Infections Testing Market Size, 2017-2028
  6.3.3 Canada Hemotransmissive Infections Testing Market Size, 2017-2028
  6.3.4 Mexico Hemotransmissive Infections Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hemotransmissive Infections Testing Revenue, 2017-2028
  6.4.2 Germany Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.3 France Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.4 U.K. Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.5 Italy Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.6 Russia Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Hemotransmissive Infections Testing Market Size, 2017-2028
  6.4.8 Benelux Hemotransmissive Infections Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hemotransmissive Infections Testing Revenue, 2017-2028
  6.5.2 China Hemotransmissive Infections Testing Market Size, 2017-2028
  6.5.3 Japan Hemotransmissive Infections Testing Market Size, 2017-2028
  6.5.4 South Korea Hemotransmissive Infections Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Hemotransmissive Infections Testing Market Size, 2017-2028
  6.5.6 India Hemotransmissive Infections Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hemotransmissive Infections Testing Revenue, 2017-2028
  6.6.2 Brazil Hemotransmissive Infections Testing Market Size, 2017-2028
  6.6.3 Argentina Hemotransmissive Infections Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemotransmissive Infections Testing Revenue, 2017-2028
  6.7.2 Turkey Hemotransmissive Infections Testing Market Size, 2017-2028
  6.7.3 Israel Hemotransmissive Infections Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Hemotransmissive Infections Testing Market Size, 2017-2028
  6.7.5 UAE Hemotransmissive Infections Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Vector-Best
  7.1.1 Vector-Best Corporate Summary
  7.1.2 Vector-Best Business Overview
  7.1.3 Vector-Best Hemotransmissive Infections Testing Major Product Offerings
  7.1.4 Vector-Best Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.1.5 Vector-Best Key News
7.2 Atlas Medical
  7.2.1 Atlas Medical Corporate Summary
  7.2.2 Atlas Medical Business Overview
  7.2.3 Atlas Medical Hemotransmissive Infections Testing Major Product Offerings
  7.2.4 Atlas Medical Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.2.5 Atlas Medical Key News
7.3 Launch Diagnostics
  7.3.1 Launch Diagnostics Corporate Summary
  7.3.2 Launch Diagnostics Business Overview
  7.3.3 Launch Diagnostics Hemotransmissive Infections Testing Major Product Offerings
  7.3.4 Launch Diagnostics Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.3.5 Launch Diagnostics Key News
7.4 Creative Diagnostics
  7.4.1 Creative Diagnostics Corporate Summary
  7.4.2 Creative Diagnostics Business Overview
  7.4.3 Creative Diagnostics Hemotransmissive Infections Testing Major Product Offerings
  7.4.4 Creative Diagnostics Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.4.5 Creative Diagnostics Key News
7.5 Shanghai Chemtron Biotech
  7.5.1 Shanghai Chemtron Biotech Corporate Summary
  7.5.2 Shanghai Chemtron Biotech Business Overview
  7.5.3 Shanghai Chemtron Biotech Hemotransmissive Infections Testing Major Product Offerings
  7.5.4 Shanghai Chemtron Biotech Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.5.5 Shanghai Chemtron Biotech Key News
7.6 Oscar Medicare
  7.6.1 Oscar Medicare Corporate Summary
  7.6.2 Oscar Medicare Business Overview
  7.6.3 Oscar Medicare Hemotransmissive Infections Testing Major Product Offerings
  7.6.4 Oscar Medicare Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.6.5 Oscar Medicare Key News
7.7 ABON Biopharm
  7.7.1 ABON Biopharm Corporate Summary
  7.7.2 ABON Biopharm Business Overview
  7.7.3 ABON Biopharm Hemotransmissive Infections Testing Major Product Offerings
  7.7.4 ABON Biopharm Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.7.5 ABON Biopharm Key News
7.8 Bio-Rad Laboratories
  7.8.1 Bio-Rad Laboratories Corporate Summary
  7.8.2 Bio-Rad Laboratories Business Overview
  7.8.3 Bio-Rad Laboratories Hemotransmissive Infections Testing Major Product Offerings
  7.8.4 Bio-Rad Laboratories Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.8.5 Bio-Rad Laboratories Key News
7.9 Trinity Biotech Manufacturing
  7.9.1 Trinity Biotech Manufacturing Corporate Summary
  7.9.2 Trinity Biotech Manufacturing Business Overview
  7.9.3 Trinity Biotech Manufacturing Hemotransmissive Infections Testing Major Product Offerings
  7.9.4 Trinity Biotech Manufacturing Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.9.5 Trinity Biotech Manufacturing Key News
7.10 Adaltis
  7.10.1 Adaltis Corporate Summary
  7.10.2 Adaltis Business Overview
  7.10.3 Adaltis Hemotransmissive Infections Testing Major Product Offerings
  7.10.4 Adaltis Hemotransmissive Infections Testing Revenue in Global Market (2017-2022)
  7.10.5 Adaltis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemotransmissive Infections Testing Market Opportunities & Trends in Global Market
Table 2. Hemotransmissive Infections Testing Market Drivers in Global Market
Table 3. Hemotransmissive Infections Testing Market Restraints in Global Market
Table 4. Key Players of Hemotransmissive Infections Testing in Global Market
Table 5. Top Hemotransmissive Infections Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemotransmissive Infections Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemotransmissive Infections Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemotransmissive Infections Testing Product Type
Table 9. List of Global Tier 1 Hemotransmissive Infections Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemotransmissive Infections Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hemotransmissive Infections Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemotransmissive Infections Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemotransmissive Infections Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hemotransmissive Infections Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemotransmissive Infections Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemotransmissive Infections Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hemotransmissive Infections Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemotransmissive Infections Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemotransmissive Infections Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemotransmissive Infections Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemotransmissive Infections Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemotransmissive Infections Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemotransmissive Infections Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemotransmissive Infections Testing Revenue, (US$, Mn), 2023-2028
Table 30. Vector-Best Corporate Summary
Table 31. Vector-Best Hemotransmissive Infections Testing Product Offerings
Table 32. Vector-Best Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 33. Atlas Medical Corporate Summary
Table 34. Atlas Medical Hemotransmissive Infections Testing Product Offerings
Table 35. Atlas Medical Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 36. Launch Diagnostics Corporate Summary
Table 37. Launch Diagnostics Hemotransmissive Infections Testing Product Offerings
Table 38. Launch Diagnostics Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 39. Creative Diagnostics Corporate Summary
Table 40. Creative Diagnostics Hemotransmissive Infections Testing Product Offerings
Table 41. Creative Diagnostics Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 42. Shanghai Chemtron Biotech Corporate Summary
Table 43. Shanghai Chemtron Biotech Hemotransmissive Infections Testing Product Offerings
Table 44. Shanghai Chemtron Biotech Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 45. Oscar Medicare Corporate Summary
Table 46. Oscar Medicare Hemotransmissive Infections Testing Product Offerings
Table 47. Oscar Medicare Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 48. ABON Biopharm Corporate Summary
Table 49. ABON Biopharm Hemotransmissive Infections Testing Product Offerings
Table 50. ABON Biopharm Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 51. Bio-Rad Laboratories Corporate Summary
Table 52. Bio-Rad Laboratories Hemotransmissive Infections Testing Product Offerings
Table 53. Bio-Rad Laboratories Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 54. Trinity Biotech Manufacturing Corporate Summary
Table 55. Trinity Biotech Manufacturing Hemotransmissive Infections Testing Product Offerings
Table 56. Trinity Biotech Manufacturing Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)
Table 57. Adaltis Corporate Summary
Table 58. Adaltis Hemotransmissive Infections Testing Product Offerings
Table 59. Adaltis Hemotransmissive Infections Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hemotransmissive Infections Testing Segment by Type in 2021
Figure 2. Hemotransmissive Infections Testing Segment by Application in 2021
Figure 3. Global Hemotransmissive Infections Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemotransmissive Infections Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemotransmissive Infections Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemotransmissive Infections Testing Revenue in 2021
Figure 8. By Type - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 12. US Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 16. Germany Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 24. China Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemotransmissive Infections Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemotransmissive Infections Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Vector-Best Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Atlas Medical Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Launch Diagnostics Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Creative Diagnostics Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shanghai Chemtron Biotech Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Oscar Medicare Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ABON Biopharm Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bio-Rad Laboratories Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Trinity Biotech Manufacturing Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Adaltis Hemotransmissive Infections Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)